Congressional record
Jared Moskowitz bought Amgen Inc. stock on APR 16, 2025.
Jared Moskowitz — a trade near an FDA decision
The FDA approved a product from Amgen Inc. on APR 18, 2025.
2 days separated the trade and the FDA action.
8 of Moskowitz's disclosed trades fall within three weeks of an FDA decision.
Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
SOURCE: STOCK ACT DISCLOSURES, HOUSE CLERK · OPENFDA, U.S. FOOD & DRUG ADMINISTRATION